Treatment of recurrent pediatric myelodysplastic syndrome post hematopoietic stem cell transplantation.
Treatment of recurrent pediatric myelodysplastic syndrome post hematopoietic stem cell transplantation.
复制标题
DOI：
10.1002/ccr3.8190
复制
发表时间：
2023-11
影响因子：
0.7
通讯作者：
中科院分区：
文献类型：
--
作者：
造血细胞移植（HCT）后复发性骨髓增生异常综合征（MDS）的治疗仍然具有挑战性。我们报告了一名4岁女孩，在HCT后经历了早期MDS复发，采用多模式治疗策略，包括第二次HCT和创新的靶向治疗。我们强调综合治疗方法在治疗复发性小儿MDS方面的潜力。
Treatment of recurrent myelodysplastic syndrome (MDS) after hematopoietic cell transplantation (HCT) remains challenging. We present a 4‐year‐old girl experiencing early MDS relapse post‐HCT treated with a multimodal strategy encompassing a second HCT and innovative targeted therapies. We underscore the potential of a comprehensive treatment approach in managing recurrent pediatric MDS.